Medication info
Cozalex Q Tab 10/50 mg

Cozalex Q Tab 10/50 mg

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tabletAmlodipine Camsylate›15.68mg / 1 tablet
Manufacturer / importer
Korea Organon Co., Ltd.
Appearance
Pink rectangular film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201006205 · Approved 2010.10.15 · Insurance code 073100040

Summary

Main use
Treatment of essential hypertension; initial treatment of Stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy with either component, switching directly to this medicine may be considered as follows: - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with combination therapy compared with monotherapy. The usual dose is 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ∘ Patients with renal impairment: No dosage adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients on dialysis. ∘ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See Section 1, Warnings, in Precautions for Use.) ∘ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ∘ Elderly patients: In patients aged 75 years or older, the recommended initial dose of losartan is 25 milligrams once daily; therefore, use of this medicine as initial treatment is not recommended.
Child dose
∘ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Korea Organon Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; initial treatment of Stage 2 hypertension

  • Essential hypertension
  • Stage 2 hypertension
View approved original text

This medication is used to effectively lower blood pressure in patients with essential hypertension who have difficulty controlling blood pressure with monotherapy of amlodipine or losartan. It is also suitable for patients with Stage 2 hypertension when treatment is initiated with a combination therapy to achieve target blood pressure from the beginning. This drug helps stabilize blood pressure, reduces the risk of cardiovascular diseases, and improves overall health. Therefore, it can be actively recommended as a therapeutic agent for patients who need blood pressure control.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy with either component, switching directly to this medicine may be considered as follows: - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with combination therapy compared with monotherapy. The usual dose is 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ∘ Patients with renal impairment: No dosage adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients on dialysis. ∘ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See Section 1, Warnings, in Precautions for Use.) ∘ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ∘ Elderly patients: In patients aged 75 years or older, the recommended initial dose of losartan is 25 milligrams once daily; therefore, use of this medicine as initial treatment is not recommended.

Child dose

∘ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication may cause serious harm to the fetus, especially after the second trimester of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Care should be taken in patients with reduced effective blood volume, such as those taking diuretics, as symptoms of hypotension may occur. This drug should not be administered to patients with allergies to its components or similar medications, severe liver dysfunction, aortic stenosis, or in shock. Patients with diabetes or moderate to severe renal impairment should avoid use, as it poses risks when combined with certain medications. Due to blood pressure-lowering effects, dizziness may occur, so driving or operating hazardous machinery should be avoided. Care should be taken when this drug is taken with potassium-sparing diuretics, potassium supplements, etc., as it may cause dangerously high blood potassium levels. Adverse reactions such as dizziness, headache, edema, palpitations, skin rash, and difficulty breathing may occur, and if symptoms are severe, consultation with a healthcare professional is advised. Elderly patients, especially those over 75 years, require initial dose adjustments for this medication; inadequate starting doses may increase the risk of side effects. Patients with reduced liver or kidney function require regular monitoring before and after taking this medication, and any abnormal signs should be reported to a healthcare professional immediately. This medication is not recommended for children, as safety and efficacy have not been established. In case of overdose, severe hypotension, tachycardia, and deterioration of heart and respiratory function may occur, requiring immediate emergency assistance. It is advisable to avoid grapefruit juice while taking this medication and to be cautious of interactions when combined with other antihypertensive medications. Breastfeeding women should preferably avoid taking this medication, and if necessary, should consult with a healthcare professional. This medication should be kept out of reach of children and care should be taken not to transfer it to other containers.

Side effects

Dizziness, headache, drowsiness, cerebral infarction, weakness, chest discomfort, chest pain, early satiety, peripheral edema, pitting edema, abdominal discomfort, indigestion, nausea, gastroesophageal reflux disease, constipation, itching, urticaria, palpitations, flushing, orthostatic hypotension, facial flushing, dyspnea, cough, vertigo, conjunctival injection, increased urinary frequency, arthralgia, sleep apnea syndrome, uterine fibroids, uterine prolapse, hyperlipidemia, osteoporosis, diabetes, gastric ulcer, hypoglycemia, pneumonia, cerebral hemorrhage, death, cerebral infarction, hypotension, chest pain, sudden death, myocardial infarction, angina pectoris, fracture, sepsis, gastric cancer, angioedema, vasculitis, tension hypertension, sensory loss, dysesthesia, peripheral neuropathy, syncope, taste disturbance, tremor, erectile dysfunction, gynecomastia, change in bowel habits, dry mouth, pancreatitis, vomiting, hyperglycemia, weakness, fatigue, pain, weight gain, weight loss, hypotension, vasculitis, insomnia, mood changes, cough, rhinitis, hair loss, increased sweating, purpura, skin discoloration, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urinary frequency, urinary disorders, nocturia, hepatitis, jaundice, elevated liver enzymes, skin rash, maculopapular rash, heaviness, warmth, impaired glucose tolerance, weakness, excessive peripheral vasodilation in cases of severe overdose, reflex tachycardia, systemic hypotension, non-cardiogenic pulmonary edema, hypotension, tachycardia, bradycardia, angioedema (causing airway obstruction), anaphylactic reaction, hepatitis, liver dysfunction, malaise, anemia, thrombocytopenia, rhabdomyolysis, taste disturbance, dry cough, erythema, hyperkalemia, hyponatremia, elevated ALT, syncope, loss of consciousness, acute hepatitis, fulminant hepatitis, anaphylaxis syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius. This helps to preserve the effectiveness of the drug for a longer period.

Appearance and packaging

Appearance

Pink rectangular film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.